Woodstock Corp Viking Therapeutics, Inc. Transaction History

Woodstock Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 06, 2021	SELL	$5.3 - $6.71 $387,700 - $490,843	-73,151 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$6.38 - $8.73 $116,039 - $158,781	18,188 Added 33.09%	73,151 $587,000
Q3 2019 Oct 02, 2019	BUY	$6.55 - $8.6 $1,310 - $1,720	200 Added 0.37%	54,963 $378,000
Q1 2019 Apr 05, 2019	BUY	$7.58 - $9.94 $415,103 - $544,344	54,763 New	54,763 $544,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

Stay updated on Woodstock Corp with notifications on news.